Alimera Sciences Inc (ALIM.O)

ALIM.O on Consolidated Issue listed on NASDAQ Global Market

4.94USD
24 Apr 2015
Change (% chg)

-- (--)
Prev Close
$4.94
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
--
52-wk Low
--

ALIM.O

Chart for ALIM.O

About

Alimera Sciences, Inc. is a biopharmaceutical company. The Company researches, develops and commercializes the prescription of ophthalmic pharmaceuticals. The Company focuses on diseases affecting the back of the eye. The Company’s product is ILUVIEN, an implant providing a therapeutic effect for up to 36 months in the treatment... (more)

Overall

Beta: 1.31
Market Cap(Mil.): $219.10
Shares Outstanding(Mil.): 44.35
Dividend: --
Yield (%): --

Financials

  ALIM.O Industry Sector
P/E (TTM): -- 41.06 41.71
EPS (TTM): -0.89 -- --
ROI: -63.22 16.86 16.20
ROE: -- 17.36 17.00
Search Stocks

Earnings vs. Estimates

Search Stocks